Loading...
Genetic screening for neovascular AMD: cost effective…not so quick
The following is a response to Brown and colleagues (Int J Retin Vitr 1:19, 2015), who analyzed the cost effectiveness of genetic screening for neovascular AMD in Category 3 (intermediate). As explained in this letter, it is premature to propose that genetic screening is cost effective in this setti...
Na minha lista:
| Udgivet i: | Int J Retina Vitreous |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5088460/ https://ncbi.nlm.nih.gov/pubmed/27847617 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40942-015-0024-5 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|